Sam Fazeli

Sam Fazeli is a Bloomberg Intelligence analyst specializing in the pharmaceutical and biotechnology sectors. He offered insights into Johnson & Johnson's strategic decisions, emphasizing the company's cautious stance in light of potential tariff impacts. Fazeli's expertise contributes to the understanding of market dynamics affecting pharmaceutical companies during turbulent times.